Free e-Newsletter

Enter e-mail

Updated: 10/11/2008

Foreign IP strategy for manufacturing executives

 

Globalization has created significant opportunities for manufacturing companies in the outsource contract manufacturing sector -- across various end-market segments and industries. However, along with these opportunities has surfaced an unwanted risk against one of a company's most valuable assets - its intellectual property (IP), including patents and trade secrets.

The increase in a company's IP risk profile warrants placing ever more importance on foreign patent filing IP strategies developed and implemented by companies and, the growing role that business, product marketing, and technical executives must play in developing company IP strategy in conjunction with sound legal counsel.

Foreign patent filing IP strategies have significant implications regarding the scope of patent rights afforded to a company. Business, marketing, and technical executives don't necessarily have to understand the minutia of patent prosecution, however, these executives should be intimately involved in strategic decisions regarding which jurisdictions companies should pursue product patent protection.

This decision process should not be ad-hoc. IP strategy and foreign patent filing decisions must be aligned with a company's business priorities, objectives, and goals.

Foreign patent filing diversity

As an example of how diverse and comprehensive foreign patent filing IP strategies can be, let's look at jurisdictional patent family members for patents filed -- whose primary US Class is 600/300 - for medical surgery, diagnostic testing products.

Table 1 displays foreign and domestic applications from 1997 to 2007. Note: PCT refers to Patent Cooperation Treaty.

 

 Table 1
 

United States Class 600/300
Filing Jurisdictions

Medical Surgery &
Diagnostic Testing Products
       
  Country Original Patents  
       
  Slovakia 1  
  Singapore 2  
  Turkey 2  
  Argentina 3  
  Greece 4  
  Latvia 4  
  Indonesia 5  
  Netherlands 5  
  Italy 6  
  Czech Republic 8  
  Finland 9  
  Switzerland 15  
  Hong Kong 16  
  Poland 18  
  South Africa 19  
  Portugal 20  
  Hungary 21  
  Urasian 24  
  France 25  
  Ukraine 26  
  Denmark 36  
  Sweden 42  
  Taiwan 45  
  Russia 59  
  Norway 75  
  United Kingdom 84  
  Spain 104  
  South Korea 114  
  Mexico 148  
  New Zealand 149  
  Israel 188  
  Brazil 192  
  Austria 273  
  China 343  
  Germany 684  
  Japan 1,029  
  Canada 1,109  
  Australia 1,971  
  European 2,505  
  PCT 3,025  
  United States 10,457  
       
  Total 22,865  

 

As illustrated above, companies in this particular medical technology space filed foreign patent filings in more than 35 jurisdictions -- at tremendous cost. Although the United States is the dominant jurisdiction, many other jurisdictions have also been integral to the foreign patent filing IP strategies for the organizations filing.

Foreign patent filing IP strategy considerations

How do executives choose which jurisdictions to file patents in? How can executives align their foreign patent filing IP strategy with their company's strategic business objectives in a cost-effective manner?

Average rating
(0 votes)

Post new comment

Comments are reviewed by the administrator and published after approval. Please keep your comments appropriate and on topic.

(Your e-mail address will not be published)